Omnicell, Inc. (NASDAQ:OMCL) had its price target upped by research analysts at Cantor Fitzgerald to $58.00 in a research report issued on Friday, October 27th, The Fly reports. The firm presently has an “overweight” rating on the stock. Cantor Fitzgerald’s price target points to a potential upside of 28.04% from the stock’s previous close.
Other equities analysts also recently issued reports about the stock. Dougherty & Co upped their price target on shares of Omnicell from $45.00 to $49.00 and gave the company a “buy” rating in a report on Friday, July 28th. Craig Hallum boosted their price objective on shares of Omnicell from $46.00 to $52.00 and gave the company a “buy” rating in a research report on Friday, July 28th. BidaskClub cut shares of Omnicell from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Zacks Investment Research raised shares of Omnicell from a “sell” rating to a “hold” rating in a research report on Tuesday, July 4th. Finally, Piper Jaffray Companies reissued a “hold” rating and issued a $40.00 price objective on shares of Omnicell in a research report on Sunday, July 30th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $54.86.
Shares of Omnicell (OMCL) opened at $45.30 on Friday. Omnicell has a fifty-two week low of $31.50 and a fifty-two week high of $55.40. The company has a current ratio of 1.53, a quick ratio of 1.08 and a debt-to-equity ratio of 0.38.
Omnicell (NASDAQ:OMCL) last posted its earnings results on Thursday, October 26th. The company reported $0.42 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.42. The firm had revenue of $186.78 million for the quarter, compared to the consensus estimate of $192.45 million. Omnicell had a negative net margin of 0.51% and a negative return on equity of 0.79%. The business’s quarterly revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.40 EPS. research analysts expect that Omnicell will post 0.12 EPS for the current year.
TRADEMARK VIOLATION WARNING: This piece was first posted by Week Herald and is the property of of Week Herald. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://weekherald.com/2017/11/15/cantor-fitzgerald-boosts-omnicell-inc-omcl-price-target-to-58-00.html.
In other Omnicell news, EVP Dan S. Johnston sold 16,400 shares of the company’s stock in a transaction that occurred on Friday, August 18th. The shares were sold at an average price of $48.86, for a total transaction of $801,304.00. Following the transaction, the executive vice president now owns 51,621 shares in the company, valued at approximately $2,522,202.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Jorge R. Taborga sold 6,295 shares of the stock in a transaction on Monday, November 6th. The stock was sold at an average price of $48.69, for a total transaction of $306,503.55. Following the completion of the sale, the vice president now owns 50,013 shares in the company, valued at approximately $2,435,132.97. The disclosure for this sale can be found here. Insiders have sold a total of 47,632 shares of company stock worth $2,370,955 in the last 90 days. 3.77% of the stock is currently owned by company insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Pinebridge Investments L.P. boosted its holdings in Omnicell by 1.6% during the second quarter. Pinebridge Investments L.P. now owns 4,896 shares of the company’s stock worth $211,000 after buying an additional 76 shares in the last quarter. Arizona State Retirement System boosted its holdings in Omnicell by 0.5% during the second quarter. Arizona State Retirement System now owns 19,384 shares of the company’s stock worth $835,000 after buying an additional 100 shares in the last quarter. 1st Global Advisors Inc. boosted its holdings in Omnicell by 1.5% during the second quarter. 1st Global Advisors Inc. now owns 7,948 shares of the company’s stock worth $343,000 after buying an additional 120 shares in the last quarter. Municipal Employees Retirement System of Michigan boosted its holdings in Omnicell by 2.6% during the first quarter. Municipal Employees Retirement System of Michigan now owns 8,340 shares of the company’s stock worth $339,000 after buying an additional 210 shares in the last quarter. Finally, Sawgrass Asset Management LLC boosted its holdings in Omnicell by 4.6% during the second quarter. Sawgrass Asset Management LLC now owns 7,525 shares of the company’s stock worth $324,000 after buying an additional 330 shares in the last quarter. 98.64% of the stock is currently owned by hedge funds and other institutional investors.
Omnicell, Inc provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence.
Receive News & Ratings for Omnicell Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell Inc. and related companies with MarketBeat.com's FREE daily email newsletter.